SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950130-01-505267
Filing Date
2001-11-13
Accepted
2001-11-13 00:00:00
Documents
8
Period of Report
2001-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q (HTML) d10q.htm 10-Q 199666
3 1994 LILLY STOCK PLAN dex101.txt EX-10.1 25374
4 1998 LILLY STOCK PLAN dex102.txt EX-10.2 31755
5 CHANGE IN CONTROL SEVERANCE PAY PLAN dex103.txt EX-10.3 42276
6 CHAIRMAN OF THE BOARD LETTER dex104.txt EX-10.4 3696
7 STATEMENT RE: COMPUTATION OF EARNINGS PER SHARE dex11.txt EX-11 2937
8 STATEMENT RE: COMPUTATION OF RATIO OF EARNINGS dex12.txt EX-12 2480
9 CAUTIONARY STATEMENT UNDER PRIVATE SECURITIES dex99.txt EX-99 5491
  Complete submission text file 0000950130-01-505267.txt   316087
Mailing Address LILLY CORPORATE CENTER DROP CODE 1112 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1112 INDIANAPOLIS IN 46285 3172762000
LILLY ELI & CO (Filer) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-06351 | Film No.: 1782321
SIC: 2834 Pharmaceutical Preparations